Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Bixlenvo Sunlenca Starter Pack (copackaged) (bictegravir sodium, lenacapavir sodium, lenacapavir sodium)FDA approves Bixlenvo Sunlenca Starter Pack (copackaged) (bictegravir sodium, lenacapavir sodium, lenacapavir sodium)27 August 2026The FDA approved Bixlenvo Sunlenca Starter Pack (copackaged) (bictegravir sodium, lenacapavir sodium, lenacapavir sodium), a drug from Gilead Sciences Inc. Form: Tablet, Oral. Application NDA221443.FDA New Drug Approvals calendarMore from this calendar

20 October 2026 - FDA approves Hibsago (bepirovirsen)

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))